Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Journal of Clinical MedicineOpen Access

How to Read a Next-Generation Sequencing Report for AML and MDS? What Hematologists Need to Know

View Full Paper
Ask AI
Bookmark
Share

Authors

SPSalvatore PerroneCTCristina TresoldiSRSilvia Rigamonti

Discussion

Loading...

Member takes

Overview

Observational analysis highlights the utility of next-generation sequencing for diagnosing AML, indicating key prognostic models derived from gene mutations like TP53.

Key Points

  • Acute myeloid leukemia diagnosis utilizes next-generation sequencing and integrates quality metrics for accuracy.
  • Gene mutations identified by sequencing play a crucial role in prognostic models for AML management.
  • Whole-genome and whole-exome sequencing expand the detection capabilities for hematologic malignancies.
  • Prognostic models incorporate findings from next-generation sequencing to refine treatment strategies for AML.

Cite This Study

Perrone et al. (2025) studied this question.

synapsesocial.com/papers/69401f142d562116f28fa514https://doi.org/10.3390/jcm14248681
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Application of next-generation sequencing in the treatment of myelodysplastic syndrome: from mechanisms to clinical practice2026
  2. 2The role of next-generation sequencing in hematologic malignancies2024 · 22 citations
  3. 3Acute myeloid leukemia: recommendations for next-generation sequencing2026
  4. 4Integration of Next-Generation Sequencing in Measurable Residual Disease Monitoring in Acute Myeloid Leukemia and Myelodysplastic Neoplasm2025 · 5 citations
  5. 5Next generation sequencing based genetic landscape and its clinical implications for Egyptian patients with acute myeloid leukemia and Myelodysplastic syndrome2025